TABLE 4.
Data integration results of different characteristics.
| Outcomes | Type | Number of articles | Number of patients | Estimator | I 2 |
| Caton/Caion | RRT | 3 | 168 | 0.136 (0.017-0.255) | 85 |
| PE | 2 | 63 | 0.190 (0.112-0.492) | 90 | |
| MARS | 1 | 20 | 0.130 (0.017-0.277) | NR | |
| Overall | 6 | 251 | 0.141 (0.053-0.229) | 81 | |
| ALT | RRT | 2 | 153 | −158.139 (−496.000-179.721) | 76 |
| PE | 3 | 158 | −58.164 (−63.825-−52.502) | 0 | |
| MARS | 1 | 20 | −174.000 (−2,398.462-2,050.462) | NR | |
| Overall | 6 | 331 | −58.189 (−63.844-−52.534) | 40 | |
| AST | RRT | 2 | 153 | −419.222 (−1,217.130-378.686) | 79 |
| PE | 3 | 158 | −82.961 (−127.781-−38.140) | 66 | |
| MARS | 1 | 20 | −180.000 (−1,335.565-975.565) | NR | |
| Overall | 6 | 331 | −86.038 (−129.676-−42.400) | 62 | |
| Creatinine | RRT | 5 | 400 | −0.746 (−1.096-−0.396) | 90 |
| MARS | 2 | 69 | −0.294 (−0.517-−0.071) | 0 | |
| PE | 2 | 99 | −0.032 (−0.084-0.019) | 0 | |
| Overall | 9 | 569 | −0.515 (−0.793-−0.238) | 95 | |
| BUN | RRT | 5 | 400 | −48.043 (−68.331-−27.756) | 97 |
| MARS | 1 | 49 | 0.000 (−23.809-23.809) | 0 | |
| Overall | 6 | 449 | −41.714 (−62.925-−20.502) | 96 | |
| Platelet | RRT | 2 | 153 | −4.886 (−15.243-5.470) | 0 |
| MARS | 3 | 79 | −4.354 (−15.935−7.244) | 0 | |
| PE | 2 | 99 | −26.153 (−39.229-−13.078) | 0 | |
| Overall | 7 | 331 | −10.214 (−16.865-−3.563) | 33 | |
| APTT | RRT | 2 | 153 | −5.613 (−11.668-0.441) | 75 |
| MARS | 2 | 59 | 0.410 (−2.910-3.730) | 0 | |
| Overall | 4 | 212 | −2.919 (−7.659-1.820) | 73 | |
| INR | RRT | 2 | 153 | −0.198 (−0.393-−0.003) | 79 |
| PE | 3 | 158 | −0.673 (−1.347-0.001) | 90 | |
| Overall | 5 | 311 | −0.393 (−0.734-−0.053) | 87 | |
| HCO3– | RRT | 8 | 493 | 3.670 (2.024-5.315) | 93 |
| MARS | 1 | 20 | 1.000 (−0.753-2.753) | NR | |
| PE | 1 | 54 | 2.000 (0.911-3.089) | NR | |
| Overall | 10 | 567 | 3.284 (1.848-4.719) | 93 | |
| BE | RRT | 6 | 437 | 4.752 (3.174-6.329) | 88 |
| MARS | 1 | 20 | 2.400 (−0.098-4.898) | NR | |
| Overall | 7 | 457 | 4.501 (3.026-5.976) | 87 | |
| PCO2 | RRT | 5 | 193 | 0.553 (−1.867-2.974) | 66 |
| MARS | 1 | 20 | 1.000 (−4.259-6.259) | NR | |
| PE | 1 | 54 | −1.000 (−2.600-0.600) | NR | |
| Overall | 7 | 267 | 0.356 (−1.492-2.205) | 63 | |
| Acidosis | RRT | 4 | 247 | 0.220 (0.088-0.388) | 84 |
| Alkalosis | RRT | 5 | 427 | 0.065 (0.006-0.169) | 89 |
| Lactate | RRT | 5 | 307 | −0.540 (−1.169-0.088) | 74 |
| MARS | 1 | 49 | 0.200 (−0.139-0.539) | NR | |
| PE | 1 | 54 | 0.200 (0.040-0.360) | NR | |
| Overall | 7 | 410 | 0.286 (−0.793-0.221) | 88 | |
| Na | RRT | 6 | 261 | 0.424 (−1.247-2.095) | 81 |
| MARS | 1 | 20 | 1.000 (−1.319-3.319) | NR | |
| PE | 1 | 54 | 4.200 (2.773-5.627) | NR | |
| Overall | 8 | 335 | 0.926 (−0.615-2.468) | 84 | |
| K | RRT | 4 | 192 | −0.155 (−0.249-0.060) | 39 |
| MARS | 1 | 20 | −0.100 (−0.275-0.075) | NR | |
| PE | 1 | 54 | 0.400 (0.225-0.575) | NR | |
| Overall | 6 | 266 | −0.077 (−0.261-0.107) | 84 | |
| Hypocalcemia | RRT | 4 | 4,544 | 0.053 (0.023-0.092) | 86 |
| Hypercalcemia | RRT | 4 | 1,112 | 0.086 (0.002-0.256) | 96 |
| Sepsis | RRT | 6 | 386 | 0.379 (0.238-0.530) | 88 |
| PE | 1 | 54 | 0.296 (0.180-0.436) | NR | |
| Overall | 7 | 440 | 0.367 (0.246-0.497) | 87 | |
| Los_ICU | RRT | 6 | 237 | 16.397 (6.789-26.004) | 96 |
RRT, renal replacement therapy; CRRT, continuous renal replacement therapy; MARS, molecular adsorbent recirculation system; PE, plasma exchange; Caion, ionized calcium; Caton, total calcium; ALT, alanine transaminase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; APTT, activated partial thromboplastin time; INR, international normalized ratio; BE, base excess; ICU, intensive care unit; los_ICU, length of ICU stay; NR, not reported.